Baxter (NYSE:BAX) said today that it won a nod north of the border for its Amia automated peritoneal dialysis system. The Health Canada approval makes Amia the 1st automated peritoneal dialysis device cleared in the U.S. and Canada that includes voice guidance, touchscreen control and 2-way telemedicine features, Deerfield Park, Ill.-based Baxter said. “As a leader in home […]
Baxter
Baxter touts remote monitoring study for Amia dialysis device
Baxter (NYSE:BAX) today released the results from a study of its AMIA automated peritoneal dialysis system, touting the value of remote monitoring technology for chronic health conditions for improving access to care, decreasing hospitalization and reducing treatment costs. Results from the study were published in the academic journal Plos One this month, the company said. ”Increasing […]
J&J investor relations veep Mehrotra retires, Wolk steps up | Personnel Moves June 22, 2016
J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson (NYSE:JNJ) said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has […]
Baxter touts high compliance rate with use of Sigma Spectrum infusion systems
Baxter (NYSE:BAX) today touted compliance data from facilities equipped with its Sigma Spectrum Infusion pump system, citing an overall average of 97% drug library compliance during the 1st 30 days of implementation. Smart pump drug libraries are designed to aid clinicians in identifying mistakes before they harm patients by allowing them to choose from a curated list […]
NxStage Medical jumps on Baxter’s exit from the home hemodialysis market
Share prices for NxStage Medical (NSDQ:NXTM) jumped this week after Baxter (NYSE:BAX) CEO Joe Almeida said the company is pulling the plug on its Vivia home hemodialysis device. Almeida, speaking at the Goldman Sachs investor conference June 7, said he evaluated the home dialysis market after he took over the corner office in October 2015. “That […]
Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter (NYSE:BAX) today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for treating chronic and acute renal failure. The study data was presented at the European Renal Association and European Dialysis and Transplant Association’s 53rd Congress this week. ”Regardless of where dialysis therapy is performed […]
Partnerships and the pursuit of innovation at large and small companies
Anne Sissel, managing director of Baxter Ventures and Adam Berman, CEO of TVA Medical, Inc. shared their perspectives on topics related to innovation and partnership between large, commercial organizations and small, venture-backed start-ups. Anne E. Sissel, M.B.A., C.F.A. is managing director of Baxter Ventures and has been in that role since she joined the company […]
Baxter said to be front-runner in $1.2B race for India’s Gland Pharma
Baxter (NYSE:BAX) is the front-runner in the chase for has emerged as the frontrunner to buy India’s Gland Pharma for as much as $1.2 billion, according to the Economic Times. Hyderabad-based Gland, which is partially owned by private equity giant KKR, is a contract manufacturer of injectables. KKR bought a 40% stake for $191 million in November 2013; […]
Baxter issues 4-year forecast
Baxter (NYSE:BAX) yesterday said it hopes to grow earnings per share to $3 over the next 4 years, as it looks to improve its operating margins and grow the top line. The Chicago-area healthcare giant said it expects to post adjusted EPS of 2.10 to $2.25 in 2018, on sales growth of 3% to 4% on a […]
Wright Medical COO, ex-Tornier CEO Mowry, steps down | Personnel Moves May 5, 2016
Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more
Baxter boosts Baxalta share exchange offer
Baxter (NYSE:BAX) said today that its raising the size of its offer to exchange its own shares for those of its Baxalta (NYSE: BXLT) pharmaceuticals spinout ahead of its acquisition by Shire (NSDQ:SHPGY). Baxter cut its stake in Baxalta in January from 19.4% to 13.8%. In March, Deerfield, Ill.-based Baxter exchanged about 59.4 million Baxalta shares at $39.40 apiece, leave […]